Close

Ultragenyx Pharma (RARE) Tops Q1 EPS by 8c

May 4, 2017 4:46 PM EDT

Ultragenyx Pharma (NASDAQ: RARE) reported Q1 EPS of ($1.63), $0.08 better than the analyst estimate of ($1.71).

For earnings history and earnings-related data on Ultragenyx Pharma (RARE) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings